Ozempic vs Mounjaro vs Wegovy - Weight Loss Drug Comparison 2026
Complete comparison of Ozempic, Mounjaro, and Wegovy for weight loss and diabetes. Compare effectiveness, side effects, cost, availability, and which is right for you.
Overview
GLP-1 receptor agonists have revolutionized weight management and diabetes treatment. Ozempic, Mounjaro, and Wegovy are the three most prescribed medications in this class, but they work differently and are approved for different purposes. This guide compares everything you need to know.
Disclaimer: This article is for informational purposes only. Always consult your healthcare provider before starting any medication.
Quick Comparison
| Feature | Ozempic | Mounjaro | Wegovy |
|---|---|---|---|
| Manufacturer | Novo Nordisk | Eli Lilly | Novo Nordisk |
| Generic Name | Semaglutide | Tirzepatide | Semaglutide |
| FDA Approved For | Type 2 Diabetes | Type 2 Diabetes + Weight Loss | Weight Loss |
| Mechanism | GLP-1 only | GLP-1 + GIP (dual) | GLP-1 only |
| Administration | Weekly injection | Weekly injection | Weekly injection |
| Average Weight Loss | 10-15% | 15-22% | 12-17% |
| Max Dose | 2 mg/week | 15 mg/week | 2.4 mg/week |
| List Price (monthly) | ~$935 | ~$1,023 | ~$1,349 |
| Insurance Coverage | ✅ (diabetes) | ✅ (diabetes + weight) | ⚠️ Limited |
How They Work
Mechanism of Action
| Mechanism | Ozempic | Mounjaro | Wegovy |
|---|---|---|---|
| GLP-1 Receptor | ✅ | ✅ | ✅ |
| GIP Receptor | ❌ | ✅ | ❌ |
| Appetite Reduction | ✅ | ✅ | ✅ |
| Gastric Emptying | Slows | Slows significantly | Slows |
| Insulin Secretion | ✅ Glucose-dependent | ✅ Enhanced | ✅ Glucose-dependent |
| Glucagon Suppression | ✅ | ✅ | ✅ |
Mounjaro's dual-action (GLP-1 + GIP) mechanism is what sets it apart. By targeting two hormone receptors, it achieves greater weight loss and blood sugar control than single-receptor medications.
Weight Loss Effectiveness
Clinical Trial Results
| Metric | Ozempic (2mg) | Mounjaro (15mg) | Wegovy (2.4mg) |
|---|---|---|---|
| Average Weight Loss | 10-15% | 15-22.5% | 12-17% |
| 68-week Trial Loss | 14.9% | 22.5% | 16.9% |
| ≥5% Weight Loss | 77% of patients | 91% of patients | 83% of patients |
| ≥10% Weight Loss | 54% of patients | 79% of patients | 66% of patients |
| ≥20% Weight Loss | 19% of patients | 57% of patients | 32% of patients |
| Waist Reduction | ~5 inches | ~7 inches | ~6 inches |
Mounjaro leads in every weight loss metric, with patients losing an average of 22.5% of body weight in clinical trials — approaching the results of bariatric surgery for some patients.
Blood Sugar Control (A1C Reduction)
| Metric | Ozempic | Mounjaro | Wegovy |
|---|---|---|---|
| A1C Reduction | -1.5 to -1.8% | -2.0 to -2.4% | -1.3 to -1.6% |
| Fasting Glucose | Significant drop | Largest drop | Moderate drop |
| Diabetes Remission | Possible | Most likely | Not primary use |
| Cardiovascular Benefit | ✅ Proven (SELECT trial) | ✅ Proven (SURPASS) | ✅ Proven |
Dosing Schedule
Ozempic
| Week | Dose | Purpose |
|---|---|---|
| 1-4 | 0.25 mg | Initiation |
| 5-8 | 0.5 mg | Titration |
| 9-12 | 1.0 mg | Therapeutic |
| 13+ | 2.0 mg | Maximum (if needed) |
Mounjaro
| Week | Dose | Purpose |
|---|---|---|
| 1-4 | 2.5 mg | Initiation |
| 5-8 | 5.0 mg | Titration |
| 9-12 | 7.5 mg | Titration |
| 13-16 | 10 mg | Therapeutic |
| 17-20 | 12.5 mg | Therapeutic |
| 21+ | 15 mg | Maximum |
Wegovy
| Week | Dose | Purpose |
|---|---|---|
| 1-4 | 0.25 mg | Initiation |
| 5-8 | 0.5 mg | Titration |
| 9-12 | 1.0 mg | Titration |
| 13-16 | 1.7 mg | Titration |
| 17+ | 2.4 mg | Maintenance |
Side Effects
| Side Effect | Ozempic | Mounjaro | Wegovy |
|---|---|---|---|
| Nausea | 20-44% | 12-18% | 25-44% |
| Diarrhea | 8-12% | 12-17% | 10-30% |
| Vomiting | 5-10% | 5-9% | 6-25% |
| Constipation | 5-8% | 6-12% | 5-24% |
| Abdominal Pain | 5-7% | 5-8% | 5-7% |
| Injection Site Reaction | ~1% | ~1% | ~1% |
| Pancreatitis Risk | Low | Low | Low |
| Thyroid C-cell Warning | ✅ Black box | ✅ Black box | ✅ Black box |
Side effects typically decrease after 4-8 weeks as the body adjusts. Mounjaro tends to have milder GI side effects compared to semaglutide-based medications.
Cost & Insurance Coverage
| Factor | Ozempic | Mounjaro | Wegovy |
|---|---|---|---|
| List Price | ~$935/mo | ~$1,023/mo | ~$1,349/mo |
| With Insurance (diabetes) | $25-$150 | $25-$150 | Not covered |
| With Insurance (weight) | Not approved | $25-$250 | $0-$500 |
| Manufacturer Coupon | ✅ Available | ✅ Available | ✅ Available |
| Generic Available | ❌ (2031+) | ❌ (2036+) | ❌ (2031+) |
| Compounded Version | ⚠️ Available | ⚠️ Available | ⚠️ Available |
Insurance tip: Ozempic and Mounjaro are far easier to get covered when prescribed for Type 2 Diabetes. Wegovy coverage for weight loss varies significantly by insurer.
Who Should Consider What?
Ozempic is best if:
- You have Type 2 Diabetes as primary concern
- Your insurance covers it for diabetes
- You want a well-established medication with long safety data
- Cardiovascular risk reduction is important
Mounjaro is best if:
- Maximum weight loss is your goal
- You have Type 2 Diabetes AND want weight loss
- You want potentially fewer GI side effects
- You're looking for the most effective option
Wegovy is best if:
- You need weight management without diabetes
- Your BMI is ≥30 (or ≥27 with comorbidities)
- Your insurance covers weight loss medications
- You want the FDA-approved weight loss indication
Verdict
Mounjaro is the most effective option overall, delivering the highest weight loss (up to 22.5%) and best blood sugar control. Its dual-action mechanism gives it a clear clinical advantage.
Ozempic is the most established and widely prescribed, with the longest track record and proven cardiovascular benefits.
Wegovy is essentially the same drug as Ozempic (semaglutide) at a higher dose, specifically approved for weight management rather than diabetes.
Our recommendation: Talk to your doctor about Mounjaro first if your insurance covers it — the clinical data is compelling. If you have diabetes, Ozempic is the proven workhorse. If weight loss is your primary goal without diabetes, Wegovy or Mounjaro (now approved for weight loss) are your best options.